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Abstract
Background: Early miscarriage is one of the most common obstetric causes of maternal morbidity early in
pregnancy. However, data concerning non-fatal complications among hospitalisations for early miscarriage are
lacking. The aim of this study was to determine whether there were changes in the incidence, management and
outcomes of early miscarriage hospitalisations between 2005 and 2016.
Methods: This is a nationwide population-based study of 50,538 hospitalisations with a diagnosis of
early miscarriage of all acute maternity hospitals in Ireland. Electronic health records were retrieved using the
Hospital In-Patient Enquiry database. Main outcomes include the incidence rates of hospitalisations and
management for early miscarriage, and rates of blood transfusion and length of stay over 2 days.
Results: Overall, 50,538 hospitalisations for early miscarriage were identified from 2005 to 2016. The risk of
hospitalisation decreased from 70.6 per 1000 deliveries (95% CI 68.4 to 72.8) in 2005 to 49.7 per 1000 deliveries
(95% CI 49.7 to 53.3) in 2016; however, the risk of blood transfusion increased over time (ratio: 2.0; 95% CI 1.6 to 2.4).
Women of advanced maternal age had a higher risk of hospitalisations. There were less blood transfusions among
women who undertook medical treatment (ratio: 0.3; 95% CI 0.1 to 0.5), but they had an increased risk of staying over
2 days at the hospital (ratio: 1.5; 95% CI 1.2 to 1.9) compared to evacuation of retained products of conception.
Conclusions: Hospitalisation rates for early miscarriage decreased over time with an increase in risk of blood
transfusion and an extended length of stay at the hospital. Women who underwent medical management did not
have as many blood transfusions as those undergoing surgical management. However, they had an increased risk of
an extended stay. Research is needed to explore both outpatient and inpatient settings in order to improve the
management and care provided.
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Plain English summary
Approximately, 1 out of 4 women will experience an
early miscarriage in their reproductive life. Despite the
burden of early miscarriage, there is a lack of informa-
tion regarding trends in incidence rates of hospitalisa-
tions and type of management of early miscarriage, but
also about the morbidities associated to hospitalisations
of early miscarriage. Therefore, the objectives of this
study were to explore national trends in incidence rates
of hospital admissions for early miscarriage in the Re-
public of Ireland from January of 2005 to December of
2016, and to estimate morbidity associated with blood
transfusion and length of stay over 2 days.
This is a retrospective population-based study using
the Hospital In-Patient Enquiry (HIPE). The HIPE is a
computer-based system designed to collect demo-
graphic, clinical and administrative data on discharges
and deaths in the Republic of Ireland. However data
from the emergency department and outpatient settings
are not available.
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Over this period of time there were approximately
50,000 hospitalisations for early miscarriage. Early mis-
carriage hospitalisations became 19% less common dur-
ing 2005–2016 but the risk of blood transfusion
doubled. The risk of an extended length of stay also in-
creased over the same time period. Women who under-
went medical management did not have as many blood
transfusions compare to those who had surgical manage-
ment. However, women who underwent medical treat-
ment had a higher risk of a prolonged stay at the
hospital. More research is needed to explore the patterns
of care and morbidities associated to hospitalisation in
order to improve protocols of management and the care
provided for women who miscarry.
Background
Miscarriage is one of the most common complication in
early pregnancy [1–3]. It is clinically classified as either
early miscarriage, within 13 weeks of gestation, or late
miscarriage, between 13 and before 24 completed weeks
of pregnancy [1, 4–6]. Early miscarriage occurs in 10 to
30% of all pregnancies [7, 8] and in 11 to 16% of all clin-
ically recognised pregnancies [9, 10]. Late miscarriage is
estimated to occur in less than 1% [11, 12]. Despite the
burden of early miscarriage, to our knowledge, no stud-
ies have published national trends in incidence rates of
hospitalisations for early miscarriage.
The pathways of care for early miscarriage have
evolved [13]. Traditionally, the “gold standard treatment”
for early miscarriage was surgical uterine evacuation [6].
The introduction and improvement in sensitivity of
transvaginal scans (TVS) has helped to diagnose miscar-
riage early in pregnancy [6, 14]. Furthermore, medical
management, using misoprostol [15], and expectant
management are acceptable alternative to surgery, which
are currently offered to haemodynamically stable pa-
tients [13, 16]. However, the optimal management for
miscarriage and their associated adverse effects are still
being investigated [17].
Hospitalisations during pregnancy are indicative of se-
vere complications [18]. Early miscarriage is associated
with less severe complications than ectopic pregnancy
[19]; however, heavy bleeding is one of the clinical com-
plications why women who miscarry are admitted to
hospital [6, 20]. Moreover, second-trimester miscarriage,
while less common, almost always requires inpatient ad-
mission and senior obstetric input [11]. Yet, clear and
generalised evidence concerning morbidities among hos-
pitalisations for early miscarriage are lacking [21].
Therefore, this study aimed to explore national trends in
incidence rates of hospitalisations for early miscarriage,
to explore trends in management, and to estimate the
associated morbidity of blood transfusion and length of
stay.
Methods
Study design and data source
A retrospective population-based study was conducted
using the Hospital In-Patient Enquiry (HIPE) database. All
inpatient admissions for early miscarriage in all public
maternity hospital settings in the Republic of Ireland
from January 1st 2005 to 31st December 2016 were
included. The HIPE is an anonymous national health
computer-based system designed to collect demo-
graphic, clinical and administrative data on discharges
and deaths from all 62 acute hospitals in the Republic
of Ireland [22, 23]. Therefore, outpatient data, (i.e.
emergengcy department, day patient, early pregnancy
assessment units or post-anaesthetic care department)
are not available [22, 23]. Outpatient and inpatient
data are not linked at a national level in the Republic of
Ireland, and therefore, this study was unable to report
how many hospitalisation of early miscarriage were re-
ferred from emergency department or other outpatient
settings. The Economic and Social Research Institute on
behalf of the Health Service Executive is the executive
organism which administerd and managed the HIPE
database [24].
Population
From 2005, the 10th Revision Australian modification of
International Statistical Classification of Disease and Re-
lated Health Problems (ICD-10-AM) and the Australian
Refined Diagnosis Related Groups are the coding classifi-
cation systems of diagnosis used in the HIPE system
[22]. All miscarriage hospitalisations within the HIPE
dataset were identified using the diagnostic codes for
outcome of miscarriage (O03). The unit of analysis was
the annual number of delivery discharges within the
HIPE dataset using the diagnostic code for outcome of
delivery (Z37). According to the ICD-10-AM, miscar-
riage is defined as the spontaneous expulsion or ex-
traction of the productos of conception by any
means, before viability, that being less than 22nd
weeks of pregnancy. Miscarriage can be classified as
complete miscarriage (i.e. when productos of concep-
tion are not evident on ultrasound), but also incom-
plete miscarriage (i.e. when patient is admitted
because of retained products of conception). However,
HIPE data does not specify gestational age in single
weeks but uses ranges between < 5, 5 to 13, 14 to 19,
20 to 25, 26 to 33 and 34 to 36 completed weeks of
gestation. Therefore, our analysis were restricted to
early miscarriage, which was defined as a miscarriage
before 14 completed weeks.
Outcomes measures and independent variables
This study included blood transfusion as a complication
and length of stay as an indicator of efficiency.
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Diagnostic codes for blood transfusion were identified
using codes within the HIPE dataset (920,600 &
9,206,200 &1,370,601–1,370,603). Length of stay was
automatically obtained using the menu of the HIPE
database. Hospitalisations with length of stay greater
than 2 days were also considered a complication for the
purpose of this study.
Demographic and pregnancy-related variables within
the HIPE dataset included year of discharge, maternal
age (in years) and public or private health insurance. All
women who are pregnant and ordinarily resident in the
Republic of Ireland are entitled to free maternity care,
covering antenatal visits, labour and delivery and postna-
tal care under the Maternity and Infant Care Scheme
[25]. Those inpatient admissions who were treated under
the Maternity and Infant Care Scheme were classified as
public patients. The only alternative option is to be
treated using private health insurance were classified as
private patients.
Management for early miscarriage was categorised as
surgical and medical treatment. Women were classified as
being managed expectantly when neither of the previous
procedures codes were identified (i.e. other treatments) or
when women had no recorded procedures in HIPE. Surgi-
cal treatment included evacuation of retained products of
conception. Evacuation of retained products of conception
applied when a code for one of the following procedures
was recorded: curettage of uterus with (D&C) or without
dilatation (3,564,300, 35,640–00 & 35,640–01), suction
curettage of uterus (3,564,003 & 3,564,301), dilation and
evacuation of uterus (D&E) (35643–03). Medical treat-
ment of early miscarriage involving specific types of pros-
taglandin E1 (i.e. misoprostol and cervagem) or
mifepristone could not be identified as no procedure
codes are recorded in HIPE to indicate administration of
these drugs. Instead, medical management using codes for
prostaglandin, as a general group, or oxytocin were used
as the reference medical treatment for early miscarriage.
A more detailed description of the principal procedures
codes is included in Additional file 1.
In the Republic of Ireland, women with no signs of in-
fection (i.e. vaginal discharge), excessive bleeding, pyr-
exia or abdominal pain are offered expectant or medical
management from the outpatient departments. Surgical
management of early miscarriage should be offered to
women who make a specific request, who change their
mind during the course of conservative or medical man-
agement, who have heavy bleeding and/or severe pain,
when gestational trophoblastic disease is suspected or
when infected intrauterine tissue is present [6].
Statistical analysis
Hospitalisation incidence rates were estimated using the
annual number of inpatient discharges for early miscarriage
divided by the annual number of delivieries in the Republic
of Ireland over the 12-year period (2005–2016). The crude
and adjusted incidence rate ratio of hospitalisation for
early miscarriage with 95% confidence intervals (CI) were
calculated using univariate and multivariable Poisson re-
gression. All analyses were adjusted by year of discharge,
maternal age, public versus private patient and weeks of
gestation. The crude and adjusted incidence rate ratio with
95% CI for blood transfusion and length of stay over 2 days
was calculated using a multivariable Poisson regression
model. Data analysis was performed using Stata software
(version 12) and IBM SPSS Statistics for Windows (version
21.0).
Results
In total, 50,538 hospitalisations for early miscarriage up
to 14 completed weeks of gestation and 801,764 deliver-
ies were identified between January 2005 and December
2016. Overall, the rate for hospitalisation of early miscar-
riage was 63.0/1000 deliveries (95% CI 62.5 to 63.6;
Table 1). Approximately 59.0% (n = 29,835) of early mis-
carriages were diagnosed as incomplete miscarriage.
Almost 99.4% of all women admitted to maternity hospitals
were between 5 to 13weeks of gestation (n= 50,252).
The rates for women with early miscarriage decreased
from 70.6/1000 deliveries (95% CI 68.4 to 72.8) in 2005
to an incidence rate of 51.5/1000 deliveries (95% CI 49.7
to 53.3) in 2016 (Fig. 1). The risk of being hospitalised
for early miscarriage increased steadily with age, with
the exception of women aged between 25 to 29 years
old, who had a lower risk (adjusted incidence rate ratio
0.61; 95% CI 0.59 to 0.63). Women of 40 years of age or
older had approximately a three-fold increaded risk of
being hospitalised than women younger than 25 years
old (adjusted incidence rate ratio 3.34; 95% CI 3.22 to
3.45). Public patients had almost double the risk of being
hospitalised compared to private patients (Table 1).
Among hospitalisations for early miscarriage over the
same time period, evacuation of retained products of
conception was undertaken in almost half of the total
sample (n = 22,897; 45.3%), and only 2.8% were medically
managed (n = 1404). Half of the women were expectantly
managed (n = 26,225; 51.9%); among those, only 3.5%
had other type of treatment (n = 914). Expectant man-
agement remained the most frequent type of treatment
over the study period (Fig. 1). Evacuation of retained
products of conception gradually decreased from 38.0/
1000 deliveries (95% CI 36.4 to 39.6) in 2005 to 22.3/
1000 deliveries (95% CI 21.1 to 23.5) in 2016. Medical
management steadily increased over time from 0.4/1000
deliveries (95% CI 0.2 to 0.5) in 2005 to 1.6/1000 deliver-
ies (95% CI 1.3 to 1.9) in 2016 (Fig. 1). The average
length of stay for early miscarriage fluctuated during the
12-year period from 1.3 days (SD 0.8) in 2005 to 1.2 (SD
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0.7) days in 2016; with an overall average of 1.2 days (SD
0.7) (Fig. 2). Approximately 86.4% (n = 43,679) of inpa-
tients for early miscarriage stayed in hospital for 1 day
and 10.0% (n = 5049) stayed for 2 days, with only 3.6%
(n = 1810) having a length of stay of more than 2 days.
Among the 50,538 hospitalisations for early miscar-
riage, 554 (1.1%) had a blood transfusion and 1810
(3.6%) had a length of stay longer than 2 days (Table 2).
The risk of blood transfusion among hospitalisations for
early miscarriage increased over time. No significant
Table 1 Incidence rate and incidence rate ratio of hospitalisations for early miscarriage in the Republic of Ireland, 2005–2016
Deliveries No of hospitalisations for early
miscarriage
Ratea (95% CI) Crude incidence rate ratio
(95% CI)
Adjusted incidence rate ratio b
(95% CI)
All 801,764 50,538 63.0 (62.5–63.6)
Year
2005–
2008
257,750 17,958 69.7 (68.7–70.7) 1.0 (ref. group) 1.0 (ref. group)
2009–
2012
285,751 17,956 62.8 (61.9–63.8) 0.93 (0.91–0.95) 0.85 (0.84–0.88)
2013–
2016
258,263 14,624 56.6 (55.7–57.5) 0.95 (0.93–0.97) 0.77 (0.75–0.78)
Maternal Age
< 25 109,812 6404 58.3 (56.9–59.7) 1.0 (ref. group) 1.0 (ref. group)
25–29 177,647 9071 51.1 (50.0–52.1) 0.60 (0.58–0.62) 0.61 (0.59–0.63)
30–34 281,961 14,697 52.1 (51.3–53.0) 0.90 (0.87–0.92) 1.10 (1.02–1.10)
35–39 191,970 14,250 74.2 (73.0–75.4) 1.27 (1.24–1.31) 1.60 (1.55–1.65)
40+ 40,374 6116 151.5 (147.7–
155.3)
2.60 (2.51–2.69) 3.34 (3.22–3.45)
Health insurance
Private 200,014 8951 44.8 (43.8–45.7) 1.0 (ref. group) 1.0 (ref. group)
Public 601,750 41,587 69.1 (68.4–69.8) 1.38 (1.35–1.41) 1.87 (1.83–1.92)
aRate per 1000 deliveries; b Adjusted incidence rate ratio from multivariable analysis including all variables in the table
Fig. 1 National hospitalisation rates for early miscarriage and type of management
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differences were found for maternal age and risk of
blood transfusion, except for those women who were 25
to 29 years old compared to those younger than 25 years
old. Public patients had more than double the risk of a
blood transfusion than private patients (adjusted inci-
dence rate ratio 2.5; 95% CI 1.9 to 3.3). Women who
were medically, expectantly treated or who had another
type of treatment had less blood transfusions as those
undergoing evacuation of retained products of conception
(adjusted incidence rate ratio 0.3; CI 0.1 to 0.5 & adjusted
incidence rate ratio 0.3; 95% CI 0.2 to 0.4 respectively). In-
complete miscarriage had almost two times the rate of
blood transfusion compared to early miscarriage (adjusted
incidence rate ratio 1.5; 95% CI 1.1 to 2.0; Table 2).
The incidence rate ratio for length of stay over 2 days
among hospitalisations for early miscarriage was reduced
from 2009 to 2012 compared to 2005–2008 and was in-
creased from 2013 to 2016 compared to 2005–2008
(Table 2). The risk of a prolonged stay at the hospital
was reduced with advanced maternal age. Public patients
had almost twice the risk of having a length of stay over
2 days than private patients (adjusted incidence rate ra-
tio 1.7; 95% CI 1.5 to 1.9; Table 2). Women who were
medically treated had almost twice the risk of having a
length of stay over 2 days compared to those undergoing
evacuation of retained products of conception (adjusted
incidence rate ratio 1.5; CI 1.2 to 1.9). Women who were
expectantly treated or who had another type of treat-
ment were less likely to have a prolonged stay at the
hospital compared to those treated with evacuation of
retained products of conception (Table 2). Finally, no
significant differences were found between complete and
incomplete miscarriage and the risk of an extended stay
at the hospital.
Discussion
This is a population-based study including more than 50
thousand hospitalisations for early miscarriage. The inci-
dence of early miscarriage hospitalisations became 19%
less common during 2005–2016, but the risk of blood
transfusion doubled. Women aged 40 years or older had
a three-fold risk of hospitalisation than those aged 25
years; and public patients had twice the rate. Women
undergoing medical management did not have as many
blood transfusion as those undergoing evacuation of
retained products of conception; whereas it increased the
risk of length of stay over 2 days. Incomplete miscarriage
was associated with an increased risk of blood transfusion.
It is well-documented that older maternal age is a risk
factor for adverse pregnancy outcomes [26–28] and this
is further supported by the results in our study. For
example,
the maternal and fetal loss cohort study in Denmark
also found that women in their late 30s or older had a
higher risk of having ectopic pregnancy, miscarriage or
stillbirth, irrespective of their reproductive history [28].
We found no other study assessing the possible impact
of health insurance coverage on the risk of complica-
tions among hospital admissions for early miscarriage.
In order to promote a equal provision of care to
Fig. 2 Average length of stay (days) of hospitalisations for early miscarriage
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pregnant women who miscarry in hospital settings, this
possible association should be investigated.
It is important to highlight the possible impact of the
modification of the ultrasound values used to diagnose
early miscarriage. This change was made to reduce false
positive cases of early miscarriage (i.e. a patient who
may have an early sonogram with unknown viability and
another sonogram where fetal heart activity is found) at
an international level in 2011, 2012 and 2013 by the
Royal College of Obstetrician and Gynaecologists [29],
the UK National Institute for Health and Care Excel-
lence [30] and the American College of Radiology [31]
respectively. As in other countries, the Royal College of
Physicians of Ireland also modified their guidelines in
2011 [6, 32]. One of the recommendations was to per-
form a second ultrasound scan to confirm the diagnosis
of miscarriage when pregnancies are under 8 weeks of
gestation [6]. Although the rate of hospitalisations was
reducing before the guidelines, it is sometimes the case
that guidelines are produced after a period of time when
clinical practice has already been changing. For example,
the reduction of the incidence of early miscarriage dur-
ing 2005–2011 may suggest an improvement in
early miscarriage diagnosis in the years leading up to the
revised clinical guidance.
In contrast to our results, studies carried out by The
National Institute for Health and Care Excellent found
that women with a miscarriage who are managed ex-
pectantly have a higher risk of blood transfusion and
more days of bleeding compared to those who have sur-
gical treatment [3, 33]. One possible explanation for
these divergent results is that pregnant women with se-
vere haemorrhage or pain were excluded from some ran-
domized controlled trials [34–37]. Another explanation
could be that we were unable to explore if women who
were surgically managed had initially been expectantly
or medically treated as an outpatient. For example, it is
well-documented that there is a higher risk of bleeding
and unplanned intervention after expectant or medical
management compared to surgical treatment (4, 38);
Table 2 Blood transfusion and length of stay over 2 days for hospitalisations of early miscarriage, 2005–2016
Blood Transfusion Length of stay over 2 days
No of hospitalisations
for early miscarriage
n % Crude incidence
rate ratio (95% CI)
Adjusted incidence
rate ratio a (95% CI)
n % Crude incidence
rate ratio (95% CI)
Adjusted incidence
rate ratio a (95% CI)
All 50,538 554 1.1 1810 3.6
Year
2005–2008 17,958 143 0.8 1.0 (ref. group) 1.0 (ref. group) 645 3.6 1.0 (ref. group) 1.0 (ref. group)
2009–2012 17,956 182 1.0 1.3 (1.0–1.6) 1.3 (1.1–1.7) 555 3.1 0.9 (0.8–1.0) 0.9 (0.8–1.0)
2013–2016 14,624 229 1.6 2.0 (1.6–2.4) 2.0 (1.6–2.4) 610 4.2 1.2 (1.0–1.3) 1.2 (1.0–1.3)
Maternal age
< 25 6404 75 1.2 1.0 (ref. group) 1.0 (ref. group) 310 4.8 1.0 (ref. group) 1.0 (ref. group)
25–29 9071 78 0.9 0.7 (0.5–1.0) 0.7 (0.5–1.0) 350 3.9 0.8 (0.7–0.9) 0.9 (0.7–0.9)
30–34 14,697 154 1.0 0.9 (0.7–1.2) 0.8 (0.6–1.1) 469 3.2 0.7 (0.6–0.8) 0.7 (0.6–0.8)
35–39 14,250 166 1.2 1.0 (0.8–1.3) 0.9 (0.7–1.2) 465 3.3 0.7 (0.6–0.8) 0.7 (0.6–0.8)
40+ 6116 81 1.3 1.1 (0.8–1.5) 1.0 (0.7–1.4) 216 3.5 0.7 (0.6–0.9) 0.8 (0.7–0.9)
Health insurance
Private 8951 56 0.6 1.0 (ref. group) 1.0 (ref. group) 200 2.2 1.0 (ref. group) 1.0 (ref. group)
Public 41,587 498 1.2 1.9 (1.5–2.5) 2.5 (1.9–3.3) 1610 3.9 1.7 (1.5–2.0) 1.7 (1.5–2.0)
Management
ERPCb 22,897 427 1.9 1.0 (ref. group) 1.0 (ref. group) 870 3.8 1.0 (ref. group) 1.0 (ref. group)
Medical
treatment
1404 8 0.6 0.3 (0.2–0.6) 0.3 (0.1–0.5) 90 6.4 1.7 (1.4–2.1) 1.5 (1.2–1.9)
Expectant/
other
treatment
26,225 119 0.5 0.2 (0.2–0.3) 0.3 (0.2–0.4) 850 3.2 0.9 (0.8–0.9) 0.7 (0.6–0.8)
Type of early miscarriage
Complete 20,700 89 0.4 1.0 (ref. group) 1.0 (ref. group) 718 3.5 1.0 (ref. group) 1.0 (ref. group)
Incomplete 29,835 464 1.6 3.6 (2.9–4.5) 1.5 (1.1–2.0) 1092 3.7 1.1 (1.0–1.2) 0.8 (0.7–1.0)
aAdjusted incidence rate ratio from multivariable analysis including all variables in the table; bERPC Evacuation of retained products of conception
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with medical management failure varying from 10 to
20% [15, 38].
The sample size of our study population is one of the
main strength of this study. In addition, the HIPE data
are recorded following standardised methods using the
ICD-10-AM diagnosis code across all the hospitals [22].
Because single weeks of gestation were not available,
analysis were restricted to early miscarriage before 14
completed weeks of gestation. Analysing second trimes-
ter miscarriage would have included pregnancy loss up
to 25 completed weeks of gestation, resulting in the in-
clusion of a number of stillbirths rather than miscar-
riages in our analysis. A limitation of the study is that
only inpatient data are available from the HIPE database
[22]. As a result this study will under-estimate the over-
all burden of early miscarriage given the lack of out-
patient data available nationally. However, this study will
probably not under-estimate the morbidity as all were
hospital based. In order to estimate the overall burden
of early miscarriage, both outpatient and inpatient cases
should be investigated.
In conclusion, maternal age, type of health insurance,
type of treatment and incomplete miscarriage signifi-
cantly affected the risk of blood transfusion and length
of stay over 2 days at the hospital after being adjusted by
confounders. However, a better understanding of the
morbidities associated with early miscarriage hospitalisa-
tions is needed to improve management and care
provided.
Additional file
Additional file 1: Diagnosis, procedures and complications codes for
miscarriage. (DOCX 13 kb)
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